Khiron says the report adheres to global reporting initiative (GRI) standards and reflects the alignment of Khiron's goals with the United Nations Sustainable Development Goals.
Khiron Life Sciences this week announced that it has received manufacturing quotas from the Colombian TQG that authorize the company to manufacture high-THC whole plant extract for both export and domestic purposes.